{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:13:34Z","timestamp":1761506014479,"version":"build-2065373602"},"reference-count":12,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.cllc.2018.03.004","type":"journal-article","created":{"date-parts":[[2018,3,17]],"date-time":"2018-03-17T00:00:16Z","timestamp":1521244816000},"page":"377-386","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Update on International Cooperative Groups Studies in Thoracic Malignancies: The Emergence of Immunotherapy"],"prefix":"10.1016","volume":"19","author":[{"given":"Navika D.","family":"Shukla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ameen A.","family":"Salahudeen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory A.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suresh S.","family":"Ramalingam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Everett E.","family":"Vokes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenwood D.","family":"Goss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy H.","family":"Decker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio V.","family":"Scagliotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony S.","family":"Mok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather A.","family":"Wakelee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl","key":"10.1016\/j.cllc.2018.03.004_bib1","article-title":"E1505: Adjuvant chemotherapy\u00a0+\/- bevacizumab for early stage NSCLC\u2014outcomes based on chemotherapy subsets","volume":"36","author":"Wakelee","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2018.03.004_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cllc.2016.06.007","article-title":"Overview of thoracic oncology trials in cooperative groups around the globe","volume":"18","author":"Salahudeen","year":"2017","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.cllc.2018.03.004_bib3","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.lungcan.2017.03.017","article-title":"A\u00a0population-based comparative effectiveness study of chemoradiation regimens and sequences in stage III non-small cell lung cancer","volume":"108","author":"Harris","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2018.03.004_bib4","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1097\/JTO.0b013e31827457db","article-title":"Mediastinal lymph node examination and survival in resected early-stage non-small-cell lung cancer in the Surveillance, Epidemiology, and End Results database","volume":"7","author":"Osarogiagbon","year":"2012","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2018.03.004_bib5","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1158\/1078-0432.CCR-15-3069","article-title":"Randomized, placebo-controlled, phase II study of veliparib in combination with carboplatin and paclitaxel for advanced\/metastatic non-small cell lung cancer","volume":"23","author":"Ramalingam","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"suppl 3","key":"10.1016\/j.cllc.2018.03.004_bib6","doi-asserted-by":"crossref","first-page":"S711","DOI":"10.1016\/S0959-8049(15)30068-X","volume":"51","author":"Stahel","year":"2015","journal-title":"Eur J Cancer"},{"issue":"suppl","key":"10.1016\/j.cllc.2018.03.004_bib7","article-title":"Neoadjuvant nivolumab in early-stage, resectable non-small cell lung cancers","volume":"35","author":"Chaft","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2018.03.004_bib8","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1200\/JCO.2002.03.055","article-title":"Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: a Southwest Oncology Group phase II study, SWOG 9019","volume":"20","author":"Albain","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"issue":"suppl","key":"10.1016\/j.cllc.2018.03.004_bib9","article-title":"A\u00a0single-arm phase II trial of afatinib in pretreated patients with advanced NSCLC harboring a HER2 mutation: the ETOP NICHE trial","volume":"35","author":"Smit","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2018.03.004_bib10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1470-2045(17)30729-5","article-title":"Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II\u2013IIIA (N1\u2013N2) EGFR-mutant NSCLC (ADJUVANT\/CTONG1104): a randomised, open-label, phase 3 study","volume":"19","author":"Zhong","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cllc.2018.03.004_bib11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.lungcan.2015.04.015","article-title":"A\u00a0phase 1 safety study of veliparib combined with cisplatin and etoposide in extensive stage small cell lung cancer: a trial of the ECOG-ACRIN Cancer Research Group (E2511)","volume":"89","author":"Owonikoko","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2018.03.004_bib12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.21037\/tlcr.2017.06.01","article-title":"Novel systemic therapy against malignant pleural mesothelioma","volume":"6","author":"Mancuso","year":"2017","journal-title":"Transl Lung Cancer Res"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730418300469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730418300469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:07:37Z","timestamp":1761505657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730418300469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1525730418300469"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2018.03.004","relation":{},"ISSN":["1525-7304"],"issn-type":[{"type":"print","value":"1525-7304"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on International Cooperative Groups Studies in Thoracic Malignancies: The Emergence of Immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2018.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}